Statistical design of REACT (Rapid Early Action for Coronary Treatment), a multisite community trial with continual data collection

Controlled Clinical Trials

Volumn 19, Issue 4, 1998, Pages 391-403

  Feldman, Henry A ^a   Proschan, Michael A ^b   Murray, David M ^c   Goff, David C ^d,e   Stylianou, Mario ^b   Dulberg, Eric ^f   McGovern, Paul G ^c   Chan, Wenyaw ^d   Mann, N Clay ^g   Bittner, Vera ^h  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f King County Emergency Medical Services   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Community intervention; Community trial design; Emergency medicine; Health promotion; Multisite trials; Power analysis; Random coefficients analysis; Surveillance studies; Two stage analytic methods

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DRUG EFFECT; EMERGENCY MEDICINE; FEMALE; HEALTH PROMOTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EMERGENCIES; EMERGENCY SERVICE, HOSPITAL; HUMANS; MYOCARDIAL INFARCTION; STATISTICS; TIME FACTORS; UNITED STATES;

EID: 0032146627     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(98)00014-2     Document Type: Article

References (27)

1. Simons-Morton DG, Goff DC, Osganian SK, et al. REACT: rationale, design, and baseline characteristics. Acad Emerg Med. In press.
2. Raczynski J., Finnegan J., Meischke H.et al. REACT. a theoretically based intervention to reduce treatment-seeking delay for acute MI symptoms Can J Cardiol. 13:1997;298B.
3. Grines C.L., DeMaria A.N. Optimal utilization of thrombolytic therapy for acute myocardial infarction. concepts and controversies J Am Coll Cardiol. 16:1990;223-231.
4. Simpson J.M., Klar N., Donner A.P. Accounting for cluster randomization. a review of primary prevention trials, 1990 through 1993 Am J Pub Health. 85:1995;1378-1383.
5. Winkleby M.A., Feldman H.A., Murray D.M. Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk. J Clin Epidemiol. 50:1997;645-658.
6. Pearson T.A., Stone E.J. Cardiopulmonary community prevention trials. directions for public health practice, policy, and research Ann Epidemiol. 7(suppl):1997;1-124.
7. Zucker D.M., Lakatos E., Webber L.S.et al. Statistical design of the Child and Adolescent Trial for Cardiovascular Health (CATCH). implications of cluster randomization Controlled Clin Trials. 16:1995;96-118.
8. Gail M.H., Byar D.P., Pechacek T.F.et al. Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT). Controlled Clin Trials. 13:1993;6-21. Erratum, Controlled Clin Trials 1993;14:253-254.
9. Murray D.M. Design and Analysis of Group-Randomized Trials. 1998;Oxford University Press, New York.
10. Donner A., Klar N. Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemol. 49:1996;435-439.
11. Bryk A.S., Raudenbush S.W. Hierarchical Linear Models. Applications and Data Analysis Methods:1992;Sage Publications, Newbury Park, CA.
12. Murray D.M., Wolfinger R.D. Analysis issues in the evaluation of community trials. progress toward solutions in SAS/STAT MIXED J Comm Psychol. CSAP(special issue):1994;140-154.
13. Koepsell T.D., Martin D.C., Diehr P.H.et al. Data analysis and sample size issues in evaluations of community-based health promotion and disease prevention programs. a mixed-model analysis of variance approach J Clin Epidemiol. 44:1991;701-713.
14. Donner A., Klar N. Cluster randomization trials in epidemiology. theory and application J Stat Plan Inf. 42:1994;37-56.
15. Goldstein H. Multilevel Models in Educational and Social Research. 1987;Oxford University Press, New York.
16. Maynard C., Weaver W.D., Lambrew C.et al. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator. data from the National Registry of Myocardial Infarction Am J Cardiol. 76:1995;548-552.
17. Hosmer D.W., Lemeshow S. Applied Logistic Regression. 1989;John Wiley &Sons, New York.
18. Zar J.H. Biostatistical Analysis. 2:1984;Prentice-Hall, Englewood Cliffs, NJ.
19. Murray D.M., Hannan P.J., Jacobs D.R.et al. Assessing intervention effects in the Minnesota Heart Health Program. Am J Epidemiol. 139:1994;91-103.
20. Dwyer J.H., MacKinnon D.P., Pentz M.A.et al. Estimating intervention effects in longitudinal studies. Am J Epidemiol. 130:1989;781-795.
21. Murray DM, Hannan PJ, Wolfinger RD, et al. Analysis of data from group-randomized trials with repeated observations on the same groups. Stat Med. In press.
22. Feldman H.A. Families of lines. random effects in linear regression analysis J Appl Physiol. 64:1988;1721-1732.
23. Donner A. A regression approach to the analysis of data arising from cluster randomization. Int J Epidemiol. 14:1985;322-326.
24. Gail M.H., Mark S.D., Carroll R.J.et al. On design considerations and randomization-based inference for community intervention trials. Stat Med. 15:1996;1069-1092.
25. Laird N.M., Ware J.H. Random-effects models for longitudinal data. Biometrics. 38:1982;963-974.
26. Littell R.C., Milliken G.A., Stroup W.W.et al. SAS System for Mixed Models. 1996;SAS Institute, Cary, NC.
27. Murray D.M., Hannan P.J. Planning for the appropriate analysis in school-based drug-use prevention studies. J Consult Clin Psychol. 58:1990;458-468.